Products for Research Use Only
RegisterLogin

Nectin-4 Knockout MCF7 Cell line

CAT: 0421-82656Size: 2 VialsDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0421-82656Size:2 Vials
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Background
Nectin-4 is part of the Nectin family and plays a crucial role in cell adhesion. Nectin-4 contains two immunoglobulin-like C2-type domains and one Ig-like V-type domain. In contrast to other Nectins, which are found extensively in adult tissues, Nectin-4 is abundant during fetal development but declines in adult life. Its expression, however, returns specifically in lung, breast, pancreas and ovarian cancers. It was shown that Nectin-4 can modulate the expression of epithelial–mesenchymal transition-related proteins via the PI3K (phosphoinositide 3-kinase) /AKT (protein B kinase) pathway. In addition, a recent study demonstrated that Nectin-4 is a cancer-specific TIGIT ligand, and its expression is also associated with poor prognostic features, suggesting it could be an efficient target for cancer immunotherapy. In 2019, the FDA approved Enfortumab vedotin-ejfv, which is a Nectin-4-directed antibody drug conjugate (ADC) used in treating metastatic urothelial cancer.
Description
Nectin-4 Knockout MCF7 Cell Line is an MCF7 breast cancer cell line in which human Nectin-4 has been genetically removed using CRISPR/Cas9 genome editing with a lentivirus encoding CRISPR/Cas9 gene and sgRNA (single guide RNA) targeting human Nectin-4.This cell line has been validated by genomic sequencing and flow cytometry.Purchase of this cell line is for research purposes only; commercial use requires a separate license. View thefull terms and conditions.
UniProt
Q96NY8
Applications
Study phenotypes resulting from Nectin-4 knockout.Use as negative control in the development of ADC or other biologics targeting Nectin-4.
Shipping Conditions
-80°C
Storage Conditions
Cells are shipped in dry ice and should immediately be thawed or stored in liquid nitrogen upon receipt. Do not use a -80°C freezer for long term storage. Contact technical support at[email protected]if the cells are not frozen in dry ice upon arrival.
Notes
The CRISPR/CAS9 technology is covered under numerous patents, including U.S. Patent Nos. 8,697,359 and 8,771,945, as well as corresponding foreign patents applications, and patent rights.License DisclosureVisitbpsbioscience.com/licensefor the label license and other key information about this product.Troubleshooting GuideVisitbpsbioscience.com/cell-line-faqfor detailed troubleshooting instructions. For all further questions, please email[email protected].

Related Products

CatalogName
78522CRISPRa (SAM) MCF7 Cell Line
60618Hippo Pathway TEAD Luciferase Reporter MCF7 cell line
78179Cas9-Expressing MCF7 Cell Pool
78712Nectin-4 Lentivirus
78539TCR Knockout Jurkat Cell Line
78342B2M Knockout Jurkat Cell Line
78549FCGR2A (CD32A) Knockout Jurkat Cell Line
78389B2M Knockout THP-1 Cell Line
78552TCR/B2M Knockout Jurkat Cell Line
78390CIITA Knockout THP-1 Cell Line

Alternative Products

CatalogName
RK-0193RABL6 Knockout Cell Line-MCF7
RK-0382NCOA3 Knockout Cell Line-MCF7
RK-0457CAV1 Knockout Cell Line-MCF7
RWT-072MCF7 Cell Line
RG-153MCF7-Luciferase Cell Line
RG-033MCF7-Cas9 Cell Line
T3727Human TDP2 CRISPR Knockout MCF7 Stable Cell Line
GTR15423714MCF7/GFP stable cell line
GTR15423745MCF7/iRFP stable cell line
ABC-RC194HMCF7 GFP Reporter Cell Line

Popular Products